ustekinumab,vedolizumab
takeda,janssen
['uste ', 'vedo', ' hs ', 'crohn', ' aa ', ' vedo', 'vedolizumab', 'ustekinumab']
#ferrente
#ddw2023 vedo and uste use as first line in cd in rwe #evolve study no difference in response or remission but high remission rates - not seen in clinical trials better mucosal healing -vedo but better persistence -uste so overall incongruent results 
IBD clinician& researcher @IBDHull.Chair:Research Committee of @BritSocGastro. Chair of ECCO CLiNCOM. @NIHRresearch lead (Y&H)own views, RT🚫endorse.⚽️@LFC fan.